FDA issued a Warning Letter to Bayer Pharma AG on 11/14/2017 as a result of this inspection.
483 Bayer AG Jan 2017

483 Bayer AG Jan 2017

Justin Boyd FDA$119.00 - Available Now

FDA investigators audited the Bayer AG - Leverkusen, Germany facility and issued 11 inspectional observations (via FDA 483) on 20 Jan 2017.

Product details

  • Category: Human Drugs
  • Number of Observations: 11
  • Inspection end: 20 Jan 2017
  • Location: Leverkusen, Germany
  • FEI: 3002806462
Add To Cart